AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
34.37
+0.75 (2.23%)
Mar 27, 2025, 4:00 PM EST - Market closed
AtriCure Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for AtriCure stock have an average target of 49.9, with a low estimate of 40 and a high estimate of 66. The average target predicts an increase of 45.18% from the current stock price of 34.37.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AtriCure stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $51 → $46 | Buy | Maintains | $51 → $46 | +33.84% | Mar 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +48.39% | Mar 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +48.39% | Mar 21, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $36 → $45 | Buy | Maintains | $36 → $45 | +30.93% | Feb 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $50 | Buy | Maintains | $40 → $50 | +45.48% | Feb 13, 2025 |
Financial Forecast
Revenue This Year
533.24M
from 465.31M
Increased by 14.60%
Revenue Next Year
600.76M
from 533.24M
Increased by 12.66%
EPS This Year
-0.62
from -0.95
EPS Next Year
-0.45
from -0.62
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 554.1M | 639.2M | 746.7M | ||
| Avg | 533.2M | 600.8M | 679.3M | ||
| Low | 510.2M | 563.5M | 630.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.1% | 19.9% | 24.3% | ||
| Avg | 14.6% | 12.7% | 13.1% | ||
| Low | 9.6% | 5.7% | 5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.51 | -0.34 | 0.17 | ||
| Avg | -0.62 | -0.45 | -0.10 | ||
| Low | -0.85 | -0.56 | -0.29 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.